Juan J Soler

Summary

Country: Spain

Publications

  1. doi request reprint Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?
    Juan José Soler-Cataluña
    Hospital General de Requena, Valencia, Spain
    COPD 7:276-84. 2010
  2. ncbi request reprint Consensus document on the overlap phenotype COPD-asthma in COPD
    Juan José Soler-Cataluña
    Hospital General de Requena, Requena, Valencia, Espana
    Arch Bronconeumol 48:331-7. 2012
  3. doi request reprint The role of pulmonology in the National Health System Chronicity Strategy
    Juan José Soler-Cataluña
    Servicio de Neumologia, Hospital Arnau de Vilanova, Valencia, España CIBER de Enfermedades Respiratorias CIBERES, España Electronic address
    Arch Bronconeumol 51:396-402. 2015
  4. pmc New GOLD classification: longitudinal data on group assignment
    Ciro Casanova
    Pulmonary Department, Hospital Universitario NTRA, SRA, de La Candelaria, Santa Cruz de Tenerife, Tenerife, Spain
    Respir Res 15:3. 2014
  5. pmc FUMEPOC: early detection of chronic obstructive pulmonary disease in smokers
    Vicente Gil-Guillen
    Departamento Medicina Clínica, Universidad Miguel Hernández de Elche Campus de San Juan, 03550 San Juan de Alicante, Alicante, Spain
    BMC Public Health 11:413. 2011
  6. doi request reprint Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients
    Juan José Soler-Cataluña
    Hospital General de Requena, Unidad de Neumología, Servicio de Medicina Interna, Paraje Casablanca s n, 46340 Requena, Valencia, Spain
    Respir Med 103:692-9. 2009
  7. doi request reprint [Health-care quality standards in chronic obstructive pulmonary disease]
    Juan José Soler-Cataluña
    Unidad de Neumología, Servicio de Medicina Interna, Hospital de Requena, Requena, Valencia, Espana
    Arch Bronconeumol 45:196-203. 2009
  8. doi request reprint [Cardiovascular comorbidity in COPD]
    Juan José Soler Cataluña
    Unidad de Neumología, Servicio de Medicina Interna, Hospital General de Requena, Valencia, Espana
    Arch Bronconeumol 45:18-23. 2009
  9. doi request reprint [Impact of efficacy and mortality studies (TORCH and UPLIFT) in bronchodilator treatment of chronic obstructive pulmonary disease]
    Juan José Soler-Cataluña
    Unidad de Neumología, Servicio de Medicina Interna, Hospital General de Requena, Valencia, Espana
    Arch Bronconeumol 45:14-20. 2009
  10. doi request reprint [Multidimensional impact of COPD exacerbations]
    Juan José Soler-Cataluña
    Unidad de Neumología, Servicio de Medicina Interna, Hospital General de Requena, Valencia, Espana
    Arch Bronconeumol 46:12-9. 2010

Collaborators

  • German Peces-Barba
  • Marc Miravitlles
  • Ernest Sala
  • Adolfo Baloira
  • Francisco Ortega
  • Jose Luis López-Campos
  • Jaume Sauleda
  • Borja G Cosio
  • Cristobal Esteban
  • José María Marín
  • Concha Pellicer Ciscar
  • Miguel Perpiñá Tordera
  • P Roman Sanchez
  • Enmanuel Salcedo-Maiques
  • Emmanuel Salcedo
  • E Martínez-Moragón
  • E Monso
  • Juan José Soler-Cataluña
  • Miguel Angel Martínez-García
  • Pilar Román-Sánchez
  • Miguel Perpiñá-Tordera
  • Miguel Angel Martínez García
  • Juan José Soler Cataluña
  • Ciro Casanova
  • Ramón Agüero
  • Joan B Soriano
  • Inmaculada Alfageme
  • Vicente Gil-Guillen
  • Pablo Catalán Serra
  • Martín Yago
  • María José Pastor
  • Pilar Román Sánchez
  • S Reyes Calzada
  • J J Soler Cataluña
  • Miguel A Martínez-García
  • Rafael Galiano-Blancart
  • Luis Cabero-Salt
  • M A Martinez Garcia
  • J J Soler-Cataluña
  • Fernando Sanchez Toril
  • M Carmen Aguar Benito
  • Isabel Mir-Viladrich
  • Nuria Feu-Collado
  • Pilar de Lucas-Ramos
  • Juan Bautista Galdiz
  • Ingrid Solanes-García
  • Alfredo De Diego-Damiá
  • Rosa Irigaray
  • Margarita Marín
  • Miryam Calle-Rubio
  • Antonia Llunell
  • Juan P de-Torres
  • Eva Balcells
  • Cristina Martinez-Gonzalez
  • José Miguel Rodríguez
  • Teodoro Montemayor
  • Juan B Galdiz
  • José Luis Viejo
  • M Cruz González
  • Jose Luis Izquierdo
  • Luis Puente
  • Josep Morera
  • Santiago Carrizo
  • Carlos Botella Estrada
  • Concepcion V Carratala Munuera
  • Manuel Yarza Cañellas
  • Alejandro Muñoz Fernández
  • Antonio Medina Toro
  • Luis Rosado-Bretón
  • Manuel Cano Arjona
  • Carmen Gómez Martín
  • Marcos Agramunt Lerma
  • Jose Luis Martínez Lázaro
  • Luis Rosado Bretón
  • Luis Maestre Amat
  • Juan Carlos Deltell Llorens
  • Adoración Revert Algarra
  • Rosa Pastor López
  • Carmen Gallego Gonzalez
  • Alfredo Ruiz Paterna
  • Jose Antonio Paradinas Rubio
  • M Isabel Boix Vera
  • Rosa Saez Fernández
  • M Pilar Vela Troncoso
  • Javier Ballestín Vicente
  • Isabel Pastor Martínez
  • Patricia Lorca Amorrich
  • Damián Crespí Capó
  • Concepción Albert Martínez
  • Manuel Yarza-Cañellas

Detail Information

Publications26

  1. doi request reprint Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?
    Juan José Soler-Cataluña
    Hospital General de Requena, Valencia, Spain
    COPD 7:276-84. 2010
    ..It can also be of help to refine the most appropriate therapeutic and preventative measures...
  2. ncbi request reprint Consensus document on the overlap phenotype COPD-asthma in COPD
    Juan José Soler-Cataluña
    Hospital General de Requena, Requena, Valencia, Espana
    Arch Bronconeumol 48:331-7. 2012
    ....
  3. doi request reprint The role of pulmonology in the National Health System Chronicity Strategy
    Juan José Soler-Cataluña
    Servicio de Neumologia, Hospital Arnau de Vilanova, Valencia, España CIBER de Enfermedades Respiratorias CIBERES, España Electronic address
    Arch Bronconeumol 51:396-402. 2015
    ..Pulmonologists can and must participate in the new chronicity models and contribute their knowledge, experience, innovation, research, and special expertise to the development of these new paradigms. ..
  4. pmc New GOLD classification: longitudinal data on group assignment
    Ciro Casanova
    Pulmonary Department, Hospital Universitario NTRA, SRA, de La Candelaria, Santa Cruz de Tenerife, Tenerife, Spain
    Respir Res 15:3. 2014
    ..Little is known about the longitudinal changes associated with using the 2013 update of the multidimensional GOLD strategy for chronic obstructive pulmonary disease (COPD)...
  5. pmc FUMEPOC: early detection of chronic obstructive pulmonary disease in smokers
    Vicente Gil-Guillen
    Departamento Medicina Clínica, Universidad Miguel Hernández de Elche Campus de San Juan, 03550 San Juan de Alicante, Alicante, Spain
    BMC Public Health 11:413. 2011
    ..Therefore, the FUMEPOC study protocol intends to analyze the validity and reliability of Vitalograph COPD-6 spirometer as simpler tool to aid screening and diagnosis of this disease in early stages in primary care surgery...
  6. doi request reprint Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients
    Juan José Soler-Cataluña
    Hospital General de Requena, Unidad de Neumología, Servicio de Medicina Interna, Paraje Casablanca s n, 46340 Requena, Valencia, Spain
    Respir Med 103:692-9. 2009
    ....
  7. doi request reprint [Health-care quality standards in chronic obstructive pulmonary disease]
    Juan José Soler-Cataluña
    Unidad de Neumología, Servicio de Medicina Interna, Hospital de Requena, Requena, Valencia, Espana
    Arch Bronconeumol 45:196-203. 2009
    ..Finally, we propose a framework on which to base the eventual accreditation of health-care quality for COPD patients...
  8. doi request reprint [Cardiovascular comorbidity in COPD]
    Juan José Soler Cataluña
    Unidad de Neumología, Servicio de Medicina Interna, Hospital General de Requena, Valencia, Espana
    Arch Bronconeumol 45:18-23. 2009
    ....
  9. doi request reprint [Impact of efficacy and mortality studies (TORCH and UPLIFT) in bronchodilator treatment of chronic obstructive pulmonary disease]
    Juan José Soler-Cataluña
    Unidad de Neumología, Servicio de Medicina Interna, Hospital General de Requena, Valencia, Espana
    Arch Bronconeumol 45:14-20. 2009
    ..Nevertheless, when inhaled corticosteroids are associated with bronchodilator treatment, their benefits seem to be enhanced...
  10. doi request reprint [Multidimensional impact of COPD exacerbations]
    Juan José Soler-Cataluña
    Unidad de Neumología, Servicio de Medicina Interna, Hospital General de Requena, Valencia, Espana
    Arch Bronconeumol 46:12-9. 2010
    ..Indeed, there is an increasing need to identify specific clinical phenotypes and personalize treatment. Consequently, an "exacerbating" phenotype is postulated as a therapeutic target of special importance...
  11. ncbi request reprint [Methodology and clinical impact of studies of mortality in chronic obstructive pulmonary disease]
    Juan José Soler-Cataluña
    Unidad de Neumología, Servicio de Medicina Interna, Hospital General, Requena, Valencia, Espana
    Arch Bronconeumol 44:21-8. 2008
    ....
  12. pmc Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
    J J Soler-Cataluña
    Unidad de Neumología, Servicio de Medicina Interna, Hospital General de Requena, Paraje Casablanca s n 46340, Requena Valencia, Spain
    Thorax 60:925-31. 2005
    ..However, little is known about the prognostic consequences of these exacerbations. A study was undertaken to investigate whether severe acute exacerbations of COPD exert a direct effect on mortality...
  13. ncbi request reprint [Prognostic factors in chronic obstructive pulmonary disease]
    Juan José Soler Cataluña
    Unidad de Neumología, Servicio de Medicina Interna, Hospital General de Requena, Requena, Valencia, Spain
    Arch Bronconeumol 43:680-91. 2007
    ....
  14. ncbi request reprint Inhaled steroids improve quality of life in patients with steady-state bronchiectasis
    Miguel A Martínez-García
    Pneumology Unit, Requena General Hospital, Valencia, Spain
    Respir Med 100:1623-32. 2006
    ..The effects of inhaled steroids upon the quality of life of patients with bronchiectasis remain unknown...
  15. ncbi request reprint Quality-of-life determinants in patients with clinically stable bronchiectasis
    Miguel Angel Martínez-García
    Pneumology Unit, La Fe University Hospital, Valencia, Spain
    Chest 128:739-45. 2005
    ..To determine the most important variables influencing health-related quality of life (HRQL) in patients with clinically stable bronchiectasis (SB)...
  16. ncbi request reprint Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke
    Miguel Angel Martínez-García
    Pneumology Unit, Requena General Hospital, Paraje Casa Blanca s n, 46320 Requena, Valencia, Spain
    Chest 128:2123-9. 2005
    ..A study was made of the role of continuous positive airway pressure (CPAP) treatment in the prevention of new vascular events following ischemic stroke or transient ischemic attack...
  17. ncbi request reprint [Bronchiectasis in the elderly. Study of serum levels of immunoglobulin G subclasses]
    Miguel Angel Martínez-García
    Unidad de Neumología, Hospital General de Requena, Valencia, Espana
    Med Clin (Barc) 129:525-9. 2007
    ..To analyze the serum levels of immunoglobulin G (IgG) subclasses in a broad range of elderly patients with bronchiectasis...
  18. ncbi request reprint Mid-arm muscle area is a better predictor of mortality than body mass index in COPD
    Juan José Soler-Cataluña
    Unidad de Neumologyía, Servicio de Medicina Interna, Hospital General de Requena, Paraje Casablanca s n, 46340 Requena, Valencia, Spain soler
    Chest 128:2108-15. 2005
    ..However, some studies suggest that muscle mass depletion (MD) is the main factor responsible for the negative effects attributable to malnutrition...
  19. ncbi request reprint Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis
    Miguel Angel Martínez-García
    Unidad de Neumología, Service of Internal Medicine, Hospital General de Requena, Paraje Casa Blanca s n, 43230, Valencia, Spain
    Chest 132:1565-72. 2007
    ..The objective of our study was to explore modifiable and nonmodifiable factors associated with lung function decline in a clinical cohort of patients with stable non-cystic fibrosis (CF) bronchiectasis...
  20. doi request reprint Factors associated with bronchiectasis in patients with COPD
    Miguel Angel Martínez-García
    Unidad de Neumología, Hospital General de Requena, Paraje Casa Blanca s n, 43230 Valencia, Spain
    Chest 140:1130-7. 2011
    ..However, the factors associated with bronchiectasis remain unknown in these patients. The objective of this study is to identify the factors associated with bronchiectasis in patients with moderate to severe COPD...
  21. ncbi request reprint Improvement in nocturnal disordered breathing after first-ever ischemic stroke: role of dysphagia
    Miguel Angel Martínez-García
    Hospital General de Requena, Unidad de Neumología Servicio de Medicina Interna, Paraje Casa Blanca s n, 46320 Requena, Valencia, Spain
    Chest 129:238-45. 2006
    ..The aim of this study was to analyze the role of dysphagia as a model of pharyngeal muscle dysfunction in the time course of nocturnal disordered breathing (NDB) in patients who experienced a first-ever ischemic stroke...
  22. ncbi request reprint [Efficacy of a training program on sleep apnea-hypopnea syndrome aimed at primary care physicians]
    Miguel Angel Martínez-García
    Unidad de Neumología Hospital General de Requena, Requena, Valencia, Spain
    Arch Bronconeumol 44:15-21. 2008
    ..The aim of this study was to analyze the impact of a primary care training program on the quality and quantity of referrals made due to suspected SAHS...
  23. doi request reprint Diagnosis of COPD in hospitalised patients
    Concha Pellicer Ciscar
    Unidad de Neumología, Hospital Francesc de Borja, Gandia, Valencia, Espana
    Arch Bronconeumol 46:64-9. 2010
    ..To examine the quality of COPD diagnosis in hospitalised patients...
  24. ncbi request reprint [The association between bronchiectasis, systemic inflammation, and tumor necrosis factor alpha]
    Miguel Angel Martínez-García
    Unidad de Neumología Hospital General de Requena, Requena, Valencia, Spain
    Arch Bronconeumol 44:8-14. 2008
    ....
  25. ncbi request reprint Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission
    S Reyes Calzada
    Service of Pneumology, Hospital Universitario La Fe, Valencia, Spain
    Respir Med 101:1909-15. 2007
    ..To evaluate adherence to guidelines when choosing an empirical treatment and its impact upon the prognosis of community-acquired pneumonia (CAP)...
  26. ncbi request reprint [Internal consistency and validity of the Spanish version of the St. George's respiratory questionnaire for use in patients with clinically stable bronchiectasis]
    M A Martinez Garcia
    Unidad de Neumología, Servicio de Medicina Interna, Hospital General de Requena, Requena, Valencia, Spain
    Arch Bronconeumol 41:110-7. 2005
    ..To analyze the reliability and validity of the St. George's Respiratory Questionnaire (SGRQ) for use in patients with clinically stable bronchiectasis...